MedTrace Logo

Detection of Latent Tuberculosis in Hemodialysis Patients

NCT00695734 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2008-06-12

No results posted yet for this study

Summary

This study aims to compare the performance of the tuberculin skin test, used for more than 50 years as a diagnostic tool for latent tuberculosis infection, with 2 blood tests which have recently become commercially available (Interferon-gamma release assays) in a population of immunosuppressed individuals with chronic renal failure undergoing long term hemodialysis

Conditions

  • Chronic Renal Failure

Sponsors & Collaborators

  • Ligue Pulmonaire Genevoise

    collaborator OTHER

  • University Hospital, Geneva

    lead OTHER

Principal Investigators

  • Jean-Paul Janssens, MD · University Hospital, Geneva

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2008-01-31
Completion
2008-01-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00695734 on ClinicalTrials.gov